
The Consumer-to-Clinical Bridge in Women's Health: Teal Health and the 2027 Coverage Rules
Dr. Dereck Mush, MD, MBAAt-home cervical cancer screening built around the FDA-authorized Teal Wand.
Teal Health, led by co-founder and chief executive Kara Egan, combines the FDA-authorized Teal Wand for self-collected HPV screening with telehealth support. Its September 2026 $22 million Series A brought total disclosed funding to $45 million.
Notable investors: .406 Ventures, Emerson Collective, Forerunner, Serena Ventures, MPower Partners.

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA